The mid-gestation triple test profile among women diagnosed with vasa previa

References

• Benirschke K, Burton GJ, Baergen RN. Pathology of the human placenta. 6th ed. Berlin: Springer-Verlag; 2012.
   Google Scholar
• Ruiter L, Kok N, Limpens J, et al. Incidence of and risk indicators for vasa praevia: a systematic review. BJOG. 2016;123:1278–1287.
   PubMed Web of Science ®Google Scholar
• Vahanian SA, Lavery JA, Ananth CV, Vintzileos A. Placental implantation abnormalities and risk of preterm delivery: a systematic review and metaanalysis. Am J Obstet Gynecol. 2015;213:S78–S90.
   PubMed Web of Science ®Google Scholar
• Silver BM. Abnormal placentation: placenta previa, vasa previa, and placenta accreta. Obstet Gynecol. 2015;126:654–668.
   PubMed Web of Science ®Google Scholar
• Sinkey RG, Odibo AO, Dashe JS. Society of Maternal-Fetal (SMFM) Publications Committee #37: diagnosis and management of vasa previa. Am J Obstet Gynecol. 2015;213:615–619.
   PubMed Web of Science ®Google Scholar
• Gagnon R, Morin L, Bly S. Diagnostic Imaging Committee; Maternal Fetal Medicine Committee, et al. SOGC clinical practice guideline: guidelines for the management of vasa previa. Int J Gynaecol Obstet. 2010;108:85–89.
   PubMed Web of Science ®Google Scholar
• Oyelese Y, Catanzarite V, Prefumo F, et al. Vasa previa: the impact of prenatal diagnosis on outcomes. Obstet Gynecol. 2004;103:937–942.
   PubMed Web of Science ®Google Scholar
• Prabhaker RK, Belogolovkin V, Yankowitz J, Spinnato JA. Abnormal placentation: evidence-based diagnosis and management of placenta previa, placenta accreta, and vasa previa. Obstet Gynecol Surv. 2012;67:503–519.
   PubMed Web of Science ®Google Scholar
• Baulies S, Maiz N, Munoz A, et al. Prenatal ultrasound diagnosis of vasa praevia and analysis of risk factors. Prenat Diagn. 2007;27:595–599.
   PubMed Web of Science ®Google Scholar
• Schachter M, Tovbin Y, Arieli S, et al. In vitro fertilization is a risk factor for vasa previa. Fertil Steril. 2002;78:642–643.
   PubMed Web of Science ®Google Scholar
• Wilkins HL. Unexplained elevated maternal serum alpha-fetoprotein: what is the appropriate follow-up? Curr Opin Obstet Gynecol. 1998;10:469–474.
   PubMed Web of Science ®Google Scholar
• Chandra S, Scott H, Dodds L, et al. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes. Am J Obstet Gynecol. 2003;189:775–781.
   PubMed Web of Science ®Google Scholar
• Kuo PL, Lin CC, Lin YH, Guo HR. Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels. J Formos Med Assoc. 2003;102:319–325.
   PubMed Web of Science ®Google Scholar
• Williams MA, Hickok DE, Zingheim RW, et al. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. Am J Obstet Gynecol. 1992;167:1032–1037.
   PubMed Web of Science ®Google Scholar
• Smorgick N, Tovbin Y, Ushakov F, et al. Is neonatal risk from vasa previa preventable? The 20-year experience from a single medical center. J Clin Ultrasound. 2010;38:118–122.
   PubMed Web of Science ®Google Scholar
• Frank M, Maymon R, Wiener Y, et al. The effect of hereditary versus acquired thrombophilia on triple test Down’s syndrome screening. Prenat Diagn. 2013;33:191–195.
   PubMed Web of Science ®Google Scholar
• Wiener Y, Frank M, Neeman O, et al. Does low molecular weight heparin influence the triple test result in pregnant women with thrombophilia?. Isr Med Assoc J. 2012;14:247–250.
   PubMed Web of Science ®Google Scholar
• Hasegawa J. Sonoembryological evaluations of the development of placenta previa and velamentous cord insertion. J Obstet Gynaecol Res. 2015;41:1–5.
   PubMed Web of Science ®Google Scholar
• Vintzileos AM, Ananth CV, Smulian JC. Using ultrasound in the clinical management of placental implantation abnormalities. Am J Obstet Gynecol. 2015;213:S70–S77.
   PubMed Web of Science ®Google Scholar
• Fox H. Effect of hypoxia on trophoblast in organ culture. A morphologic and autoradiographic study. Am J Obstet Gynecol. 1970;107:1058–1064.
   PubMed Web of Science ®Google Scholar
• Morssink LP, Sikkema-Raddatz B, Beekhuis JR, et al. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels. Prenat Diagn. 1996;16:845–851.
   PubMed Web of Science ®Google Scholar
• Salafia CM, Silberman L, Herrera NE, Mahoney MJ. Placental pathology at term associated with elevated midtrimester serum alpha-fetoprotein concentration. Am J Obstet Gynecol. 1988;158:1064–1066.
   PubMed Web of Science ®Google Scholar
• Kelly RB, Nyberg DA, Mack LA, et al. Sonography of placental abnormalities and oligohydramnios in women with elevated alphafetoprotein levels: comparison with control subjects. Am J Roentgenol. 1989;153:815–819.
   PubMed Web of Science ®Google Scholar
• Cusick W, Rodis JF, Vintzileos AM, et al. Predicting pregnancy outcome from the degree of maternal serum alphafetoprotein elevation. J Reprod Med. 1996;41:327–332.
   PubMed Web of Science ®Google Scholar
• Sharony R, Dayan D, Kidron D, et al. Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications? Arch Gynecol Obstet. 2016;293:767–770.
   PubMed Web of Science ®Google Scholar
• Ebbing C, Kiserud T, Johnsen SL, et al. Prevalence, risk factors and outcomes of velamentous and marginal cord insertions: a population-based study of 634,741 pregnancies. PLoS One. 2013;8:e70380.
   PubMed Web of Science ®Google Scholar
• Jauniaux E, Englert Y, Vanesse M, et al. Pathologic features of placentas from singleton pregnancies obtained by in vitro fertilization and embryo transfer. Obstet Gynecol. 1990;76:61–64.
   PubMed Web of Science ®Google Scholar
• Delbaere I, Goetgeluk S, Derom C, et al. Umbilical cord anomalies are more frequent in twins after assisted reproduction. Hum Reprod. 2007;22:2763–2767.
   PubMed Web of Science ®Google Scholar
• Jauniaux E, Ben-Ami I, Maymon R. Do assisted-reproduction twin pregnancies require additional antenatal care?. Reprod Biomed Online. 2013;26:107–119.
   PubMed Web of Science ®Google Scholar
• Rice JD, McIntosh SF, Halstead AC. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies. Prenat Diagn. 2005;25:234–238.
   PubMed Web of Science ®Google Scholar
• Muller F, Dreux S, Lemeur A, French Collaborative Group, et al. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome. Prenat Diagn. 2003;23:1073–1076.
   PubMed Web of Science ®Google Scholar
• Ruiter L, Kok N, Limpens J, et al. Systematic review of accuracy of ultrasound in the diagnosis of vasa previa. Ultrasound Obstet Gynecol. 2015;45:516–522.
   PubMed Web of Science ®Google Scholar